Home/Orcapedia/Does metformin increase longevity?
Possibly. The evidence is mixed, emerging or context-dependent.
Possibly. The evidence is mixed, emerging or context-dependent. There may be a real benefit, but it is usually narrower than the marketing suggests.
Metformin, derived from a compound found in the French lilac plant (Galega officinalis), has been used to treat type 2 diabetes in Europe since the 1950s and in the US since 1994; the ongoing TAME (Targeting Aging with Metformin) trial is the first large study designed specifically to test its effect on aging-related outcomes rather than diabetes.
Metformin is a prescription medication long used to manage type 2 diabetes by lowering blood sugar, taken orally as a daily pill. Some longevity-focused users obtain it off-label from physicians specifically for its purported anti-aging effects rather than diabetes.
Its longevity reputation stems from observational data suggesting diabetic patients on metformin sometimes lived longer than expected, plus its long safety record from decades of diabetes use. It's become a flagship drug in biohacker and longevity-doctor circles precisely because it's cheap, well-studied for safety, and already approved for another use.
Possibly. The evidence is mixed, emerging or context-dependent. There may be a real benefit, but it is usually narrower than the marketing suggests.
Relevant mechanisms: cardiorespiratory fitness, muscle mass, metabolic health, vascular function, sleep, social connection and cumulative risk.
A biologically plausible sentence is not yet a clinical outcome.
Expectation changes what we notice and how we interpret normal bodily variation — particularly relevant to pain, sleep quality, stress, energy, bloating, mood and recovery. That doesn't make symptoms imaginary; it makes causal interpretation harder.
A new intervention often creates structure: going to bed on time, drinking more water, training consistently, tracking symptoms. Those changes can be useful even when the advertised mechanism is weak.
People tend to try new things when a problem is unusually bad. Many fluctuating symptoms then drift back toward their usual level. The newest product receives the applause; regression to the mean receives no affiliate commission.
A new-product week can also be the week of better sleep, less alcohol, a changed diet and lower stress. Before declaring victory, ask who else was in the room.
Risk depends on the intervention. General red flags include replacing evidence-based treatment, medication interactions, extreme dieting, burns or cold injury, device contraindications, delaying diagnosis, or interpreting serious symptoms as “detox.”
If you want an honest cue for this behaviour rather than a medical claim, OrcaForte is built for exactly that job — a placebo, not a treatment.
Does metformin increase longevity? Possibly. The evidence is mixed, emerging or context-dependent. There may be a real benefit, but it is usually narrower than the marketing suggests.
Can this replace medical treatment? No. A wellness ritual can complement appropriate care, but it should not replace diagnosis, prescribed treatment or urgent assessment.
“Regression to the mean does not sell subscriptions, but it explains most of them.”